Comparison of effects of a single dose of MHYOSPHERE® PCV ID with three commercial porcine vaccine associations against Mycoplasma hyopneumoniae (Mhyo) and porcine circovirus type 2 (PCV2) on piglet growth during the nursery period under field conditions. [PDF]
Puig A +7 more
europepmc +1 more source
Antibody responses following vaccination versus infection in a porcine circovirus-type 2 (PCV2) disease model show distinct differences in virus neutralization and epitope recognition [PDF]
Porcine circovirus associated disease (PCVAD) encompasses a group of syndromes linked to infection with porcine circovirus type 2 (PCV2). Based on the hypothesis that the immune responses to vaccination versus infection are quantitatively and ...
Guo, Baoqing +9 more
core
Porcine circovirus type 2 (PCV2) and Campylobacter infection induce diarrhea in piglets: Microbial dysbiosis and intestinal disorder. [PDF]
Yang G +6 more
europepmc +1 more source
Comparative Evaluation of Growth Performance between Bivalent and Trivalent Vaccines Containing Porcine Circovirus Type 2 (PCV2) and Mycoplasma hyopneumoniae in a Herd with Subclinical PCV2d Infection and Enzootic Pneumonia. [PDF]
Um H +7 more
europepmc +1 more source
Epidemiological Survey of Porcine Circovirus Type 2 (PCV2) in Large-Scale Pig Farms in Hubei Province and Comprehensive Evaluation of Commercial Vaccine Efficacy. [PDF]
Liao W, Xi Z, Fang R, Shen B, Zhao J.
europepmc +1 more source
Development of a differential multiplex real-time PCR assay for porcine circovirus type 2 (PCV2) genotypes PCV2a, PCV2b and PCV2d. [PDF]
Wang Y +10 more
europepmc +1 more source
Amino acid mutations of porcine circovirus type 2 (PCV2) capsid protein increase virus binding to host and evade immune responses: An evaluation of viral evolution. [PDF]
Wang D +7 more
europepmc +1 more source
Phylogenetic analysis of porcine circovirus type 2 (PCV2) between 2015 and 2018 in Henan Province, China. [PDF]
Zheng G +13 more
europepmc +1 more source
Comparative field efficacy of all-in-one intradermal vaccine based on an inactivated recombinant <i>Mycoplasma hyopneumoniae</i> with an embedded/integrated porcine circovirus type 2 (PCV2) capsid protein and concurrent administration with monovalent of <i>M. hyopneumoniae</i> and PCV2 intradermal vaccine. [PDF]
Suh J, Ham S, Chae C.
europepmc +1 more source
Design of a New Vaccine Prototype against Porcine Circovirus Type 2 (PCV2), M. hyopneumoniae and M. hyorhinis Based on Multiple Antigens Microencapsulation with Sulfated Chitosan. [PDF]
Arrieta-Mendoza D +6 more
europepmc +1 more source

